US Stock MarketDetailed Quotes

ATXI Avenue Therapeutics

Watchlist
  • 3.6400
  • +0.1500+4.30%
Trading Jul 16 15:04 ET
3.43MMarket Cap0.29P/E (TTM)

About Avenue Therapeutics Company

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.

Company Profile

SymbolATXI
Company NameAvenue Therapeutics
Listing DateJun 27, 2017
Issue Price6.00
Founded2015
CEODr. Alexandra MacLean, M.D.
MarketNASDAQ
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1111 Kane Concourse,Suite 301
CityBay Harbor Islands
ProvinceFlorida
CountryUnited States of America
Zip Code33154
Phone1-781-652-4500

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Alexandra MacLean, M.D.
  • Director and Chief Executive Officer
  • 1.21M
  • David Jin
  • Principal Accounting Officer, Interim Chief Financial Officer and Chief Operating Officer
  • 260.00K
  • Dr. Jay D. Kranzler, M.D.
  • Chairman of the Board
  • 212.19K
  • Dr. Lindsay A. Rosenwald, M.D.
  • Director
  • 104.00K
  • Neil Herskowitz
  • Independent Director
  • 164.00K
  • Curtis G. Oltmans
  • Independent Director
  • 154.00K
  • Faith L. Charles
  • Independent Director
  • 154.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg